Novo Holdings A/S — 13F holdings

Novo Holdings A/S reported 25 holdings worth $1.72B in its 13F filing for Q2 2026, filed August 14, 2026. That's up 39.5% from $1.23B in Q1 2026, when it reported 22 holdings. Its 10 largest positions make up 73.5% of the portfolio.

Novo Holdings A/S's largest positions in Q2 2026

  1. EWTX EDGEWISE THERAPEUTICS INC — $217M (12.6%) · unchanged
  2. ASML ASML HOLDING N V — $189M (11.0%) · unchanged
  3. COAG HEMAB THERAPEUTICS HLDGS INC — $154M (8.9%) · new position
  4. BN Brookfield Corp — $150M (8.7%) · unchanged
  5. MPLT MAPLIGHT THERAPEUTICS INC — $132M (7.7%) · unchanged
  6. MIRM MIRUM PHARMACEUTICALS INC — $132M (7.6%) · cut 15%
  7. AVLN AVALYN PHARMACEUTICALS INC — $128M (7.4%) · new position
  8. CRM SALESFORCE INC — $61.6M (3.6%) · unchanged
  9. AVBP ARRIVENT BIOPHARMA INC — $52.1M (3.0%) · cut 23%
  10. ELVN ENLIVEN THERAPEUTICS INC — $50.8M (2.9%) · cut 22%
  11. CRINETICS PHARMACEUTICALS IN — $49.4M (2.9%) · cut 15%
  12. PHVS PHARVARIS N V — $48.4M (2.8%) · cut 20%
  13. FND FLOOR & DECOR HLDGS INC — $47.3M (2.7%) · new position
  14. PCVX Vaxcyte Inc — $46.5M (2.7%) · cut 7%
  15. FDMT 4D MOLECULAR THERAPEUTICS IN — $43.2M (2.5%) · cut 11%
  16. VRDN VIRIDIAN THERAPEUTICS INC — $39.2M (2.3%) · added 7%
  17. CLDX CELLDEX THERAPEUTICS INC NEW — $38.1M (2.2%) · cut 15%
  18. ALMS ALUMIS INC — $31.0M (1.8%) · new position
  19. XENE XENON PHARMACEUTICALS INC — $29.3M (1.7%) · unchanged
  20. BABA ALIBABA GROUP HLDG LTD — $24.7M (1.4%) · unchanged

What Novo Holdings A/S bought in Q2 2026

6 new positions and 2 positions added to.

  1. COAG HEMAB THERAPEUTICS HLDGS INC — new position, about $154M
  2. AVLN AVALYN PHARMACEUTICALS INC — new position, about $128M
  3. FND FLOOR & DECOR HLDGS INC — new position, about $47.3M
  4. ALMS ALUMIS INC — new position, about $31.0M
  5. DYN DYNE THERAPEUTICS INC — new position, about $21.3M
  6. INSM INSMED INC — new position, about $12.9M
  7. VRDN VIRIDIAN THERAPEUTICS INC — added, about $2.48M
  8. BBOT BRIDGEBIO ONCOLOGY THERAPEUT — added, about $488K

What Novo Holdings A/S sold in Q2 2026

3 positions sold out and 8 reduced.

  1. APGE APOGEE THERAPEUTICS INC — sold out, about $59.7M
  2. BMRN BIOMARIN PHARMACEUTICAL INC — sold out, about $37.8M
  3. MIRM MIRUM PHARMACEUTICALS INC — cut 15%, about $23.4M
  4. AVBP ARRIVENT BIOPHARMA INC — cut 23%, about $15.4M
  5. ELVN ENLIVEN THERAPEUTICS INC — cut 22%, about $14.2M
  6. PHVS PHARVARIS N V — cut 20%, about $12.1M
  7. CRINETICS PHARMACEUTICALS IN — cut 15%, about $8.61M
  8. CLDX CELLDEX THERAPEUTICS INC NEW — cut 15%, about $6.51M
  9. VALN Valneva SE — sold out, about $5.53M
  10. FDMT 4D MOLECULAR THERAPEUTICS IN — cut 11%, about $5.34M

Novo Holdings A/S portfolio value by quarter

What does Novo Holdings A/S own?

Its largest positions in Q2 2026 were EWTX, ASML, COAG, BN, MPLT, out of 25 holdings worth $1.72B.

What did Novo Holdings A/S buy last quarter?

In Q2 2026 it opened 6 new positions and added to 2; the largest buys were COAG, AVLN, FND.

What did Novo Holdings A/S sell last quarter?

In Q2 2026 it sold out of 3 positions and reduced 8, including APGE, BMRN, VALN.